X4 Pharmaceuticals Inc. (XFOR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.48
0.02 (5.31%)
At close: Jan 15, 2025, 10:46 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | n/a | n/a | n/a | 3.00M | n/a | 3.50M | n/a | n/a | n/a |
Cost of Revenue | 2.00M | 1.99M | 1.89M | n/a | 672.00K | 103.00K | 195.00K | 300.00K | 400.00K |
Gross Profit | -2.00M | -1.99M | -1.89M | 3.00M | -672.00K | 3.40M | -195.00K | -300.00K | -400.00K |
Operating Income | -107.52M | -87.57M | -85.11M | -59.87M | -51.70M | -45.88M | -36.13M | -24.35M | -14.82M |
Interest Income | 4.58M | 219.00K | 10.00K | 273.00K | 1.20M | 809.00K | 214.00K | n/a | n/a |
Pretax Income | -101.09M | -93.84M | -88.68M | -61.98M | -52.81M | -43.02M | -33.88M | -22.98M | -13.22M |
Net Income | -101.17M | -93.87M | -88.70M | -62.13M | -56.60M | -43.02M | -33.88M | -22.98M | -13.22M |
Selling & General & Admin | 35.51M | 27.02M | 24.70M | 20.94M | 17.64M | 18.41M | 8.01M | 6.51M | 2.12M |
Research & Development | 70.02M | 61.06M | 50.65M | 41.93M | 30.16M | 30.98M | 28.13M | 17.83M | 12.71M |
Other Expenses | n/a | -6.27M | -3.57M | -2.11M | -1.10M | -85.00K | -16.00K | 104.00K | -77.00K |
Operating Expenses | 107.52M | 88.08M | 75.35M | 62.87M | 47.80M | 46.21M | 32.27M | 21.96M | 12.67M |
Interest Expense | 5.78M | 3.99M | 3.64M | 2.69M | 2.15M | 1.04M | 2.08M | 2.52M | 472.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 107.52M | 88.08M | 75.35M | 62.87M | 47.80M | 46.21M | 32.27M | 21.96M | 12.67M |
Income Tax | 78.00K | 28.00K | 17.00K | 148.00K | 3.80M | 3.90M | 1.87M | 2.62M | 395.00K |
Shares Outstanding (Basic) | 177.81M | 63.53M | 25.75M | 20.08M | 11.53M | 459.00K | 343.64K | 928.01K | 928.01K |
Shares Outstanding (Diluted) | 177.81M | 63.53M | 25.75M | 20.08M | 11.53M | 459.00K | 343.64K | 928.01K | 928.01K |
EPS (Basic) | -0.57 | -1.48 | -3.44 | -3.09 | -4.91 | -93.73 | -98.58 | -24.76 | -14.24 |
EPS (Diluted) | -0.57 | -1.48 | -3.44 | -3.09 | -4.91 | -93.73 | -98.58 | -24.76 | -14.24 |
EBITDA | -107.10M | -87.57M | -85.11M | -58.06M | -51.70M | -45.88M | -31.60M | -20.16M | -12.35M |
Depreciation & Amortization | 419.00K | 1.99M | 1.89M | 1.23M | 672.00K | 103.00K | 195.00K | 300.00K | 389.00K |